Sign Up to like & get
recommendations!
0
Published in 2020 at "Nature Biotechnology"
DOI: 10.1038/s41587-020-0512-5
Abstract: The time from discovery to proof-of-concept trials could be reduced to 5–6 months from a traditional timeline of 10–12 months.
read more here.
Keywords:
pandemic pace;
monoclonal antibodies;
therapeutic monoclonal;
antibodies pandemic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2019.1632192
Abstract: ABSTRACT Introduction: Approved disease-modifying therapies for multiple sclerosis (MS) lessen inflammatory disease activity that causes relapses and MRI lesions. However, chronic inflammation and demyelination lead to axonal degeneration and neuronal loss, for which there currently…
read more here.
Keywords:
therapeutic strategies;
multiple sclerosis;
strategies promote;
developing therapeutic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Expert Opinion on Drug Discovery"
DOI: 10.1080/17460441.2021.1976141
Abstract: Throughout history, pandemics like the Black Death or the Spanish Flue have periodically wiped out large parts of populations. Today, history repeats itself with the on-going SARSCoV-2 pandemic, which manifests that pandemics still hold the…
read more here.
Keywords:
challenges developing;
therapeutic monoclonal;
pandemic application;
developing therapeutic ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Perspectives in Psychiatric Care"
DOI: 10.1111/ppc.13085
Abstract: Abstract Purpose The purpose of this study is to explore psychiatric nurses' experiences of developing therapeutic relationships with adult survivors of child sexual abuse (CSA). Design and Methods A qualitative descriptive design was adopted. Semistructured…
read more here.
Keywords:
nurses experiences;
developing therapeutic;
experiences developing;
relationships adult ... See more keywords